Pharmaceuticals Industry Deals and Trends in November 2022 – Partnerships, Licensing, Investments, Mergers and Acquisitions (M&A)
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Pharmaceuticals Industry Deals and Trends Report Overview
The pharmaceutical and healthcare market reported 418 deals worth $43.8 billion in November 2022. The market registered an increase in the number of mergers and acquisitions (M&As) including asset purchases and a decrease in their deal values in November 2022. Capital raising, through equity and debt offerings, reported an increase in the number of deals and in deal values.
The Pharmaceuticals Industry Deals and Trends report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceutical industry in November 2022. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceutical industry.
Pharmaceuticals Market Segmentation by Regions
The key regions in the pharmaceuticals and healthcare market are North America, Europe, Asia Pacific, and the rest of the world. North America reported an increase in the number of deals and in deal value in November 2022.
Pharmaceuticals Market Segmentation by Deal Types
The key deal types in the pharmaceuticals and healthcare market are capital raising (equity/debt offerings), PE/VC, M&A, partnerships, and licensing agreements. PE/VC segment and capital raisings (equity and debt offerings) segment recorded the highest number of deals each.
Pharmaceuticals Market Analysis, by Deal Types, 2022 (%)
For more deal type insights into the pharmaceuticals market, download a free report sample
Pharmaceuticals Market Segmentation by Therapy Areas
The key therapy areas in the pharmaceuticals and healthcare market are oncology, central nervous system, infectious disease, immunology, metabolic disorders, gastrointestinal, and cardiovascular. The oncology therapeutics market recorded the majority of equity offering deals, followed by the central nervous system therapeutics market.
Pharmaceuticals Market Analysis, by Therapy Areas, 2022 (%)
For more therapy area insights into the pharmaceuticals market, download a free report sample
Pharmaceuticals Market - Competitive Landscape
The leading financial advisors in the pharmaceuticals market are Centerview Partners LLC, Moelis & Co, Cowen Inc, SVB Financial Group, and Lazard Ltd. Centerview Partners LLC topped the M&A financial advisory league.
Pharmaceuticals Market Analysis, by Financial Advisors, 2022 (%)
To know more about the financial advisors in the pharmaceuticals market, download a free report sample
Pharmaceuticals Market Report Overview
Number of Deals | 418 |
Total Worth (2022) | $43.8 billion |
Key Regions | North America, Europe, Asia Pacific, and the Rest of the World |
Key Deal Types | PE/VC, Partnerships, M&A, Licensing Agreements, and Capital Raising (Equity/Debt Offerings) |
Key Therapy Areas | Oncology, Central Nervous System, Infectious Disease, Immunology, Metabolic Disorders, Gastrointestinal, and Cardiovascular |
Leading Financial Advisors | Centerview Partners LLC, Moelis & Co, Cowen Inc, SVB Financial Group, and Lazard Ltd |
Segments Covered in the Report
Pharmaceuticals Market Therapy Areas Outlook (Value, US$ Million, 2022)
- Oncology
- Central Nervous System
- Infectious Disease
- Cardiovascular
- Immunology
- Metabolic Disorders
- Gastrointestinal
Pharmaceuticals Market Regional Outlook (Value, US$ Million, 2022)
- North America
- Europe
- Asia Pacific
- The Rest of the World
Scope
This report provides:
- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women’s health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
- Analysis of partnership and licensing deals based on clinical stage of development of products.
- Summary of the pharmaceutical deals globally in the six months.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include – North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.
Reasons to Buy
- Enhance your decision-making capability in a more rapid and time sensitive manner.
- Find out the major deal-performing segments for investments in your industry.
- Evaluate the types of companies which are entering into partnership or licensing agreements, divesting, and acquiring assets.
- Identify companies that are aggressively looking to raise capital in the market.
- Evaluate niche therapy areas that are receiving the majority of the upfront and milestone payments in the pharmaceutical industry.
- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
- Evaluate the clinical development stages where the majority of the partnerships and licensing agreements are happening.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.
Table of Contents
Table
Figures
Frequently asked questions
-
What was the number of deals in the pharmaceuticals and healthcare market in 2022?
The pharmaceuticals and healthcare market reported 418 deals in November 2022.
-
What was the total deals worth in the pharmaceuticals and healthcare market in 2022?
The pharmaceuticals and healthcare market reported deals worth $43.8 billion in November 2022.
-
What are the key regions in the pharmaceuticals and healthcare market?
The key regions in the pharmaceuticals and healthcare market are North America, Europe, Asia Pacific, and the rest of the world.
-
What are the key deal types in the pharmaceuticals and healthcare market?
The key deal types in the pharmaceuticals and healthcare market are PE/VC, partnerships, M&A, licensing agreements, and capital raising (equity/debt offerings).
-
What are the key therapy areas in the pharmaceuticals and healthcare market?
The key therapy areas in the pharmaceuticals and healthcare market are oncology, central nervous system, infectious disease, immunology, metabolic disorders, gastrointestinal, and cardiovascular.
-
Who are the leading financial advisors in the pharmaceuticals and healthcare market?
The leading financial advisors in the pharmaceuticals and healthcare market are Centerview Partners LLC, Moelis & Co, Cowen Inc, SVB Financial Group, and Lazard Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.